Make your one-time, tribute, or recurring online gift to support brain tumour patient programs and research today:

Brain Tumour Foundation of Canada is committed to controlling the collection, use and disclosure of personal information. Brain Tumour Foundation of Canada has demonstrated that commitment by developing this privacy policy in accordance with the standards set out in the Personal Information Protection and Electronic Documents Act of Canada.
Brain Tumour Foundation of Canada uses this policy as a set of best practices to guide the development of privacy procedures and as a guide to better inform its stakeholders and the public of its initiatives to protect the privacy of personal information.
We frequently gather and use personal information during the course of our various services, programs, and activities. This information is kept in confidence and is carefully protected. Business contact information and publicly available information, such as names, addresses and telephone numbers as published in telephone directories, are not considered personal information.
We collect, use and disclose personal information only for the purposes for which it was gathered and as described at the time of collection. We only collect the information we need to fulfill these purposes. We keep all information safeguarded and we only keep information for as long as our disclosed uses require.
We offer individuals the opportunity to opt out of receiving information from Brain Tumour Foundation of Canada or to have their information used for purposes beyond those for which it was explicitly collected. Individuals may review and revise or remove their information at any time. We dispose of information we no longer require.
We regularly review our privacy practices and update our policy. Any questions relating to Brain Tumour Foundation of Canada's Privacy Policy should be directed to the attention of our Privacy Officer at Brain Tumour Foundation of Canada, 620 Colborne Street, Suite 301, London, Ontario, N6B 3R9, by phone at 1-800-265-5106, or via e-mail at smarshall@braintumour.ca.
This site contains links that Brain Tumour Foundation of Canada is not responsible for the privacy practices or the content of. The inclusion of any link does not imply endorsement by Brain Tumour Foundation of Canada of the site. Use of these sites is at the user's own risk.
Last Updated: February 2008
New research about the brain tumour treatment Bevacizumab (Avastin®) was released at the recent American Society of Clinical Oncology (ASCO) 2013 Annual Meeting. Results were presented from two recent clinical trials focused on the treatment. Because Avastin is one of the few new treatments that have been offered to brain tumour patients in recent years, Brain Tumour Foundation of Canada was eagerly awaiting these results.
Learn moreWhen Carol Kovosi talks about......
Learn moreIn 2011 Micah Nepon’s brother Jonah was diagnosed......
Learn more